MADISON DELK: Open Payments
NPI 1154838514 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$780 in 38 payments from 11 companies in 2025. Trend: 2023 $355 · 2024 $454 · 2025 $780
Food & beverage: $780
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $185 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $162 |
| Novo Nordisk Inc | 5 | $89 |
| Axsome Therapeutics, Inc. | 5 | $78 |
| ABBVIE INC. | 3 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $60 |
| Vanda Pharmaceuticals Inc. | 2 | $51 |
| Tonix Medicines, Inc. | 1 | $27 |
| Merit Medical Systems Inc | 1 | $25 |
| Lilly USA, LLC | 1 | $23 |
Products named: Veozah, CAPLYTA, Auvelity, Kerendia, HETLIOZ, QULIPTA, Ozempic, TONMYA.
Industry payments across TN — which companies pay providers there.
